This is a synthetic peptide designed for use in combination with anti-ELOVL5 antibody (Catalog #: ARP49667_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
ELOVL5
Reactivité: Humain, Singe
Hôte: Synthetic
BP
Indications d'application
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
ELOVL5
(ELOVL Fatty Acid Elongase 5 (ELOVL5))
Synonymes
zgc:63549 Peptide, elovl2 Peptide, 1110059L23Rik Peptide, AI747313 Peptide, AU043003 Peptide, HELO1 Peptide, dJ483K16.1 Peptide, rELO1 Peptide, ELOVL fatty acid elongase 5 Peptide, ELOVL family member 5, elongation of long chain fatty acids (yeast) Peptide, ELOVL fatty acid elongase 5 S homeolog Peptide, elovl5 Peptide, ELOVL5 Peptide, Elovl5 Peptide, elovl5.S Peptide
Sujet
ELOVL5 plays a role in elongation of long-chain polyunsaturated fatty acids.ELOVL5 plays a role in elongation of long-chain polyunsaturated fatty acids (Leonard et al., 2000 [PubMed 10970790]).[supplied by OMIM]. PRIMARYREFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-3003 AF338241.1 9-3011